Arvinas, Inc. (ARVN) vs Assembly Biosciences, Inc. (ASMB)

Arvinas, Inc. and Assembly Biosciences, Inc. are both Biotechnology companies. Arvinas, Inc. and Assembly Biosciences, Inc. are of similar size ($499.6M and $479.1M). Assembly Biosciences, Inc. trades at the lower P/E: 22.3× against 57.3×. Assembly Biosciences, Inc. grew revenue faster over the last twelve months: 125.1% against −15.1%. Arvinas, Inc. has the higher net margin (2.94% vs −0.06%) and the higher return on invested capital (0.00% vs 0.00%). Across the 18 metrics below, Arvinas, Inc. leads on 9 and Assembly Biosciences, Inc. on 9.

Valuation

Metric ARVN ASMB Biotechnology median
P/E 57.31 22.32 8.56
P/S 1.52 5.74 10.17
P/B 0.86 1.40 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA 4.67 n/m 0.69
EV/Sales (0.26) 1.46 9.64
Earnings yield 1.74% 4.48% (29.41%)
Free cash flow yield (43.25%) (8.98%) (23.50%)

Profitability

Metric ARVN ASMB Biotechnology median
Gross margin 97.16% 100.00% 65.16%
Operating margin (5.72%) (11.75%) 0.00%
Net margin 2.94% (0.06%) 0.00%
Free cash flow margin (65.93%) (51.53%) 0.00%
Return on equity 1.59% (0.03%) (56.66%)
Return on assets 1.17% (0.02%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARVN ASMB Biotechnology median
Revenue growth (TTM) (15.05%) 125.12% 5.64%
EPS growth (last fiscal year) 58.84% 91.78% 30.08%
Revenue growth, 5-year CAGR 58.93% 35.27% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARVN ASMB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.91 13.99 4.72
Net debt to EBITDA 5.62 17.31 0.96

Dividend

Metric ARVN ASMB Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ARVN ASMB Biotechnology median
Market cap 499.55m 479.08m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack